IFNG and neoplasm: Pretreating A375 cells overexpressing B3GNT2 with either kifunensine or BAG showed that these ten ligands and receptors are primarily N-glycosylated, aligning with our finding that kifunensine treatment had a stronger effect on T cell IFNγ secretion and tumor cell survival (Fig. 4c).